You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Rare Bone Cancer

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Ewing Sarcoma, Ewing Family of Tumors, Ewing's Tumor Metastatic Trial in United States (Vigil, Irinotecan, Temozolomide)

Active, not recruiting
  • Ewing Sarcoma
  • +12 more
  • Vigil
  • +2 more
  • Little Rock, Arkansas
  • +16 more
Feb 9, 2022

Rare Malignant Tumor Trial (Imatinib)

Not yet recruiting
  • Rare Malignant Neoplasm
  • (no location specified)
Nov 1, 2023

Tumors Trial run by the NCI (Nilotinib and Paclitaxel)

Recruiting
  • Neoplasms
  • Nilotinib and Paclitaxel
  • Bethesda, Maryland
    National Institutes of Health Clinical Center
Jan 19, 2023

Bone in Pediatric Gaucher Disease Related to Bone Pathology in

Recruiting
  • Gaucher Disease
  • Bone Diseases
    • Fairfax, Virginia
      Lysosomal and Rare disorder research and treatment center
    Nov 6, 2023

    Urothelial Cancer and Rare Genitourinary Tract Malignancies

    Recruiting
    • Urothelial Cancer
    • +4 more
      • Bethesda, Maryland
        National Institutes of Health Clinical Center
      Jan 23, 2023

      Advanced Malignant Solid Tumor, Refractory Malignant Solid Tumor Trial (biological, procedure, drug)

      Not yet recruiting
      • Advanced Malignant Solid Neoplasm
      • Refractory Malignant Solid Neoplasm
      • Atezolizumab
      • +5 more
      • (no location specified)
      Feb 4, 2023

      Adrenal Gland Pheochromocytoma, Hematopoietic and Lymphoid System Tumor, Malignant Solid Tumor Trial run by the National Cancer

      Recruiting
      • Adrenal Gland Pheochromocytoma
      • +3 more
      • Computed Tomography
      • +2 more
      • Bethesda, Maryland
      • +1 more
      Jan 3, 2023

      Rare Tumors and Cancer Predisposition in Individuals and

      Recruiting
      • Cancer
      • +3 more
        • Bethesda, Maryland
        • +1 more
        Aug 24, 2022

        Low Grade Serous Ovarian Carcinoma, Adult Type Granulosa Cell Tumor Trial in Gent, Leuven, Liège (Abemaciclib, Letrozole)

        Not yet recruiting
        • Low Grade Serous Ovarian Carcinoma
        • Adult Type Granulosa Cell Tumor
        • Gent, Oost-Vlaanderen, Belgium
        • +2 more
        May 12, 2023

        Study on Gynecological Rare Cancers

        Recruiting
        • Gynecologic Cancer
        • chemotherapy, surgery
        • Milan, Italy
        • +1 more
        Feb 21, 2023

        PSMA-PET Imaging of Salivary Gland Tumours and Other Rare

        Recruiting
        • Salivary Gland Tumor
        • Rare Malignant Neoplasm
        • 68-Ga PSMA PET scan
        • Singapore, Singapore
          National Cancer Centre Singapore
        Oct 11, 2022

        Cognitive Burden Trial in Chapel Hill (Artificial Intelligence)

        Not yet recruiting
        • Cognitive Burden
        • Artificial Intelligence
        • Chapel Hill, North Carolina
          Lineberger Comprehensive Cancer Center
        Aug 29, 2023

        Data Collection of Patients With Rare Bone Diseases

        Recruiting
        • Skeletal Dysplasia
          • Bologna, Emilia Romagna, Italy
            Irccs Istituto Ortopedico Rizzoli
          Feb 21, 2022

          Breast Cancer, Osteopenia Trial in Valencia (bone densitometry)

          Recruiting
          • Breast Cancer
          • Osteopenia
          • bone densitometry
          • Valencia, Spain
            Hospital Clínico Universitario de Valencia
          Mar 9, 2023

          Rare Cancers, Multiomics Trial in Heidelberg

          Recruiting
          • Rare Cancers
          • Multiomics
            • Heidelberg, Germany
              German Cancer Research Center
            May 2, 2023

            NSCLC Trial in Guangzhou (Neratinib tablets)

            Not yet recruiting
            • NSCLC
            • Neratinib tablets
            • Guangzhou, Guangdong, China
              Sun Yat-sen University Cancer Center
            Sep 1, 2023

            NSCLC, RET Driver Mutation, BRAF V600 Mutation Trial in Guanzhou (Toripalimab, Nab paclitaxel, Pemetrexed)

            Recruiting
            • Non-Small Cell Lung Cancer
            • +5 more
            • Toripalimab
            • +3 more
            • Guanzhou, Guangdong, China
              Guangdong Lung Cancer Institute, Guangdong Provincial People's H
            Apr 4, 2023

            Prostate Cancer Metastatic to Bone Trial in Amsterdam (Radium-223 chloride, Rhenium-188-HEDP)

            Active, not recruiting
            • Prostate Cancer Metastatic to Bone
            • Amsterdam, Netherlands
              VU University Medical Center
            Nov 16, 2020

            HER2 Mutant NSCLC Trial (Pyrotinib maleate)

            Not yet recruiting
            • HER2 Mutant Non-small Cell Lung Cancer
            • Pyrotinib maleate
            • (no location specified)
            Jun 6, 2022

            Fibrous Dysplasia of Bone.

            Completed
            • Fibrous Dysplasia of Bone
            • McCune Albright Syndrome
            • Evaluation and analysis of clinical data
            • Lyon, France
              rheumatology department, hopital Edouard Herriot
            Jun 16, 2022

            PEGylated GH for Treatment of Short Stature in Chinese

            Recruiting
            • Growth Hormone Treatment
            • Growth Disorders
            • Polyethylene glycol recombinant human growth hormone injection
            • Beijing, Beijing, China
              Department of Endocrinology, Genetics, Metabolism
            Sep 12, 2023

            Insights Into Participating in Studies for Bone Cancer

            Not yet recruiting
            • Bone Cancer
              • San Francisco, California
                Power Life Sciences
              Sep 30, 2023

              Efficacy of Immunotherapy With Rare Mutations in Non-small Cell

              Recruiting
              • Non Small Cell Lung Cancer
              • immunity therapy
              • Changsha, Hunan, China
              • +1 more
              Feb 28, 2022

              Prostate Cancer With =10 Bone Metastases Trial (Apalutamide, 89Sr, Luteinizing Hormone-Releasing Hormone Analog)

              Not yet recruiting
              • Prostate Cancer With ≤10 Bone Metastases
              • (no location specified)
              Feb 22, 2023

              European Reference Network on Rare Adult Solid Cancers

              Recruiting
              • Head and Neck Cancer
              • +4 more
              • observation
              • Brno, Czechia
              • +10 more
              Aug 1, 2022